DHEA in elderly women and DHEA or testosterone in elderly men - PubMed (original) (raw)
Randomized Controlled Trial
. 2006 Oct 19;355(16):1647-59.
doi: 10.1056/NEJMoa054629.
Robert A Rizza, Peter O'Brien, Ketan Dhatariya, Kevin R Short, Ajay Nehra, Janet L Vittone, George G Klee, Ananda Basu, Rita Basu, Claudio Cobelli, Gianna Toffolo, Chiara Dalla Man, Donald J Tindall, L Joseph Melton 3rd, Glenn E Smith, Sundeep Khosla, Michael D Jensen
Affiliations
- PMID: 17050889
- DOI: 10.1056/NEJMoa054629
Free article
Randomized Controlled Trial
DHEA in elderly women and DHEA or testosterone in elderly men
K Sreekumaran Nair et al. N Engl J Med. 2006.
Free article
Abstract
Background: Dehydroepiandrosterone (DHEA) and testosterone are widely promoted as antiaging supplements, but the long-term benefits, as compared with potential harm, are unknown.
Methods: We performed a 2-year, placebo-controlled, randomized, double-blind study involving 87 elderly men with low levels of the sulfated form of DHEA and bioavailable testosterone and 57 elderly women with low levels of sulfated DHEA. Among the men, 29 received DHEA, 27 received testosterone, and 31 received placebo. Among the women, 27 received DHEA and 30 received placebo. Outcome measures included physical performance, body composition, bone mineral density (BMD), glucose tolerance, and quality of life.
Results: As compared with the change from baseline to 24 months in the placebo group, subjects who received DHEA for 2 years had an increase in plasma levels of sulfated DHEA by a median of 3.4 microg per milliliter (9.2 micromol per liter) in men and by 3.8 microg per milliliter (10.3 micromol per liter) in women. Among men who received testosterone, the level of bioavailable testosterone increased by a median of 30.4 ng per deciliter (1.1 nmol per liter), as compared with the change in the placebo group. A separate analysis of men and women showed no significant effect of DHEA on body-composition measurements. Neither hormone altered the peak volume of oxygen consumed per minute, muscle strength, or insulin sensitivity. Men who received testosterone had a slight increase in fat-free mass, and men in both treatment groups had an increase in BMD at the femoral neck. Women who received DHEA had an increase in BMD at the ultradistal radius. Neither treatment improved the quality of life or had major adverse effects.
Conclusions: Neither DHEA nor low-dose testosterone replacement in elderly people has physiologically relevant beneficial effects on body composition, physical performance, insulin sensitivity, or quality of life. (ClinicalTrials.gov number, NCT00254371 [ClinicalTrials.gov].).
Copyright 2006 Massachusetts Medical Society.
Comment in
- Aging and fountain-of-youth hormones.
Stewart PM. Stewart PM. N Engl J Med. 2006 Oct 19;355(16):1724-6. doi: 10.1056/NEJMe068189. N Engl J Med. 2006. PMID: 17050897 No abstract available. - DHEA and testosterone in the elderly.
Page ST, Matsumoto AM, Bremner WJ. Page ST, et al. N Engl J Med. 2007 Feb 8;356(6):635; author reply 637. doi: 10.1056/NEJMc063190. N Engl J Med. 2007. PMID: 17287487 No abstract available. - DHEA and testosterone in the elderly.
Perls TT. Perls TT. N Engl J Med. 2007 Feb 8;356(6):636; author reply 637. N Engl J Med. 2007. PMID: 17288051 No abstract available. - DHEA and testosterone in the elderly.
Yasuda M, Horie S. Yasuda M, et al. N Engl J Med. 2007 Feb 8;356(6):635-6; author reply 637. N Engl J Med. 2007. PMID: 17290511 No abstract available. - DHEA and testosterone in the elderly.
Gleicher N, Barad D. Gleicher N, et al. N Engl J Med. 2007 Feb 8;356(6):636-7; author reply 637. N Engl J Med. 2007. PMID: 17290512 No abstract available. - Can dehydroepiandrosterone or testosterone replacement effectively treat the symptoms of aging?
Arlt W. Arlt W. Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):448-9. doi: 10.1038/ncpendmet0502. Epub 2007 Apr 3. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17406371 No abstract available. - Do dehydroepiandrosterone supplements have anti-aging potential?
Hahner S, Allolio B. Hahner S, et al. Nat Clin Pract Urol. 2007 Jun;4(6):302-3. doi: 10.1038/ncpuro0780. Epub 2007 Apr 10. Nat Clin Pract Urol. 2007. PMID: 17426722 No abstract available. - [DHEA: castle in the air rather than the fountain ou youth].
Resch KL. Resch KL. Forsch Komplementmed. 2007 Jun;14(3):185-6. Forsch Komplementmed. 2007. PMID: 17717903 German. No abstract available.
Similar articles
- The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E. von Mühlen D, et al. Contemp Clin Trials. 2007 Feb;28(2):153-68. doi: 10.1016/j.cct.2006.04.009. Epub 2006 May 6. Contemp Clin Trials. 2007. PMID: 16784898 Clinical Trial. - Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women.
Kenny AM, Boxer RS, Kleppinger A, Brindisi J, Feinn R, Burleson JA. Kenny AM, et al. J Am Geriatr Soc. 2010 Sep;58(9):1707-14. doi: 10.1111/j.1532-5415.2010.03019.x. J Am Geriatr Soc. 2010. PMID: 20863330 Clinical Trial. - Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, Eastell R, Wu F, Ross RJ. Merza Z, et al. Int J Androl. 2006 Jun;29(3):381-91. doi: 10.1111/j.1365-2605.2005.00612.x. Epub 2005 Dec 22. Int J Androl. 2006. PMID: 16390499 Clinical Trial. - Testosterone in older men after the Institute of Medicine Report: where do we go from here?
Harman SM. Harman SM. Climacteric. 2005 Jun;8(2):124-35. doi: 10.1080/13697130500118001. Climacteric. 2005. PMID: 16096168 Review. - Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A. Isidori AM, et al. Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93. doi: 10.1111/j.1365-2265.2005.02339.x. Clin Endocrinol (Oxf). 2005. PMID: 16117815 Review.
Cited by
- Effects of low-dose testosterone undecanoate treatment on bone mineral density and bone turnover markers in elderly male osteoporosis with low serum testosterone.
Wang YJ, Zhan JK, Huang W, Wang Y, Liu Y, Wang S, Tan P, Tang ZY, Liu YS. Wang YJ, et al. Int J Endocrinol. 2013;2013:570413. doi: 10.1155/2013/570413. Epub 2013 Mar 4. Int J Endocrinol. 2013. PMID: 23533404 Free PMC article. - Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications.
Pataky MW, Young WF, Nair KS. Pataky MW, et al. Mayo Clin Proc. 2021 Mar;96(3):788-814. doi: 10.1016/j.mayocp.2020.07.033. Mayo Clin Proc. 2021. PMID: 33673927 Free PMC article. Review. - Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.
Erlandson KM, Ng DK, Jacobson LP, Margolick JB, Dobs AS, Palella FJ Jr, Lake JE, Bui H, Kingsley L, Brown TT. Erlandson KM, et al. J Infect Dis. 2017 Jan 15;215(2):228-237. doi: 10.1093/infdis/jiw523. J Infect Dis. 2017. PMID: 27799351 Free PMC article. - Should Dehydroepiandrosterone Be Administered to Women?
Wierman ME, Kiseljak-Vassiliades K. Wierman ME, et al. J Clin Endocrinol Metab. 2022 May 17;107(6):1679-1685. doi: 10.1210/clinem/dgac130. J Clin Endocrinol Metab. 2022. PMID: 35254428 Free PMC article. Review. - Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men.
Srinivasan M, Irving BA, Frye RL, O'Brien P, Hartman SJ, McConnell JP, Nair KS. Srinivasan M, et al. J Clin Endocrinol Metab. 2010 Apr;95(4):1617-25. doi: 10.1210/jc.2009-2000. Epub 2010 Feb 5. J Clin Endocrinol Metab. 2010. PMID: 20139233 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials